Quantamental Technologies’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
DG
Quantamental Technologies's HCAT Position: Q4 2022 in Review
Quantamental Technologies sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 16,865 shares — an estimated $164K sold.
Quantamental Technologies first reported a position in HCAT in Q2 2022 and held it in 2 quarters. The position peaked at $178K in Q2 2022. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.
- Quantamental Technologies reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
- Quantamental Technologies sold 16,865 Health Catalyst shares in Q4 2022, an estimated $164K.
- Quantamental Technologies first reported a position in Health Catalyst in Q2 2022 and held it in 2 quarters.
- Quantamental Technologies's Health Catalyst position peaked at $178K in Q2 2022.
- 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.
Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.